SINGAPORE, Dec. 17, 2024 /PRNewswire/ — Globe Teleservices Pte. Ltd. (GTS), a leading global telecom solutions provider, has entered into an exclusive three-year agreement with DITO Telecommunity, the fastest-growing telecommunications provider in the Philippines. Through this strategic partnership, GTS will deliver advanced voice monetization and firewall services to DITO, enhancing the operator’s network security while unlocking new revenue opportunities.

Ashutosh Agrawal – Globe Teleservices Group CEO and Eric R. Alberto – DITO Telecommunity Corporation CEO. Ashutosh Agrawal – Globe Teleservices Group CEO and Eric R. Alberto – DITO Telecommunity Corporation CEO.

This collaboration represents a significant milestone in DITO’s ongoing efforts to broaden its service offerings and fortify its rapidly expanding subscriber base, which has surged to over 14 million users since its market debut.

Ashutosh Agrawal, Group CEO of Globe Teleservices, expressed excitement about the partnership, stating: "We look forward to supporting DITO in unlocking new revenue streams while ensuring the highest levels of network security and service quality globally not just within Philippines."

Eric R. Alberto, CEO at DITO Telecommunity, commented on the partnership, saying: "This collaboration is vital for expanding our international voice capabilities and preventing potential leakages, particularly as we continue to grow and optimize our wholesale voice business."

This agreement underscores GTS’s commitment to delivering innovative, next-generation solutions to telecom operators worldwide. Through its partnership, GTS aims to solidify its presence in the Southeast Asian market while supporting DITO’s mission to deliver affordable, high-quality telecom services to its growing subscribers.

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Despite 48% Interest, Over 90% of Global Consumers Have Reservations About AI For BF/CM

New Sinch survey reveals trust, not just technology, will influence which brands…

Fapon Biopharma Announces the enrollment of the First Patient in the Phase I Clinical Trial of FP008, A First-in-Class Immunotherapy for Solid Tumors

DONGGUAN, China, Aug 5, 2025 /PRNewswire/ — Fapon Biopharma, a biotech in…

Akeso's Cadonilimab Combined with Concurrent Chemoradiotherapy Demonstrates Promising Efficacy in Locally Advanced Cervical Cancer: Data Published at the 2025 SGO Annual Meeting

HONG KONG, March 21, 2025 /PRNewswire/ — Akeso Inc. (9926.HK) presented promising…